Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Intracystic treatments for craniopharyngioma Steinbok P; Hukin JNeurosurg Focus 2010[Apr]; 28 (4): E13Craniopharyngioma is a benign tumor histopathologically and in theory should be curable by radical resection. In practice, this tumor behaves like a chronic disease, with many issues related to the effect of the tumor itself and the various treatments on the adjacent structures, such as the pituitary stalk and gland, hypothalamus, visual apparatus, and suprasellar arteries. A multimodality approach to the management of these tumors may produce the optimal outcome, balancing disease control and quality of life. In this paper, the role of intracystic therapies is reviewed, with the major focus on intracystic bleomycin and interferon-alpha.|Antibiotics, Antineoplastic/*administration & dosage/*therapeutic use[MESH]|Bleomycin/administration & dosage/*therapeutic use[MESH]|Combined Modality Therapy[MESH]|Craniopharyngioma/diagnostic imaging/*drug therapy/radiotherapy[MESH]|Humans[MESH]|Immunologic Factors/administration & dosage/*therapeutic use[MESH]|Injections, Intralesional[MESH]|Interferon-alpha/administration & dosage/*therapeutic use[MESH]|Pituitary Neoplasms/diagnostic imaging/*drug therapy/radiotherapy[MESH]|Radionuclide Imaging[MESH]|Radiotherapy, Conformal[MESH]|Treatment Outcome[MESH] |
